|
|
|
Volumn 25, Issue 5 SUPPL., 1998, Pages 29-38
|
|
Therapeutic options for the treatment of colorectal cancer following 5- fluorouracil failure
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
CISPLATIN;
DNA TOPOISOMERASE INHIBITOR;
FLOXURIDINE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
MITOMYCIN C;
MORPHINE SULFATE;
NITROSOUREA DERIVATIVE;
SEMUSTINE;
TOPOTECAN;
TRIMETREXATE;
VINCRISTINE SULFATE;
ADULT;
AGED;
ARTIFICIAL EMBOLISM;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED STUDY;
CRYOSURGERY;
DIARRHEA;
DOSE RESPONSE;
DRUG HYPERSENSITIVITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER METASTASIS;
LIVER RESECTION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NAUSEA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
CRYOSURGERY;
DNA TOPOISOMERASES, TYPE I;
EMBOLIZATION, THERAPEUTIC;
FLUOROURACIL;
HEPATECTOMY;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
INJECTIONS, INTRALESIONAL;
LIVER NEOPLASMS;
TREATMENT FAILURE;
TRIMETREXATE;
|
|
EID: 0031755263
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (12)
|
|
References (46)
|
